BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1875450)

  • 1. The effects of the combination of phentolamine and vasopressin on hepatic and systemic hemodynamics in cirrhotic portal hypertensive dog model.
    Dan ZL; Zhao Q; Li SB
    J Tongji Med Univ; 1991; 11(1):35-8. PubMed ID: 1875450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of phentolamine in combination with pituitrin on the hepatic and systemic hemodynamics].
    Dan Z
    Zhonghua Yi Xue Za Zhi; 1990 Jul; 70(7):367-9, 26. PubMed ID: 1699642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of pituitrin or phentolamine alone or in combination on WHVP and systemic hemodynamics in patients with liver cirrhosis].
    Guo B; Tian DA; Liang KH; Li SB; Guo JY
    J Tongji Med Univ; 1990; 10(4):207-12. PubMed ID: 1711584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemodynamic effects of vasopressin, alone and in combination with nitroprusside, in patients with liver cirrhosis and portal hypertension.
    Mols P; Hallemans R; Van Kuyk M; Melot C; Lejeune P; Ham H; Vertongen F; Naeije R
    Ann Surg; 1984 Feb; 199(2):176-81. PubMed ID: 6696534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Similarity of arterial and intravenous vasopressin on portal and systemic hemodynamics.
    Barr JW; Lakin RC; Rösch J
    Gastroenterology; 1975 Jul; 69(1):13-9. PubMed ID: 1150017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on hemorrheology in dogs with cirrhotic portal hypertension.
    Dan ZL; Li SB
    J Tongji Med Univ; 1990; 10(3):146-9. PubMed ID: 2255003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug therapy for portal hypertension.
    Rector WG
    Ann Intern Med; 1986 Jul; 105(1):96-107. PubMed ID: 2872847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complications of cirrhosis. I. Portal hypertension.
    Bosch J; García-Pagán JC
    J Hepatol; 2000; 32(1 Suppl):141-56. PubMed ID: 10728801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Portohepatic pressures, hepatic function, and blood gases in the combination of nitroglycerin and vasopressin: search for additive effects in cirrhotic portal hypertension.
    Iwao T; Toyonaga A; Ikegami M; Sumino M; Oho K; Sakaki M; Nishizono M; Tanikawa K
    Am J Gastroenterol; 1992 Jun; 87(6):719-24. PubMed ID: 1590307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response of blood flow to vasopressin in the collateral left gastric vein in patients with portal hypertension.
    Matsutani S; Mizumoto H; Fukuzawa T; Ohto M; Okuda K
    J Hepatol; 1995 Nov; 23(5):557-62. PubMed ID: 8583144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haemodynamic response to intravenous vasopressin and nitroglycerin in portal hypertension.
    Westaby D; Gimson A; Hayes PC; Williams R
    Gut; 1988 Mar; 29(3):372-7. PubMed ID: 3128465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of propranolol on hepatic and systemic hemodynamics in dogs with chronic bile duct ligation.
    Willems B; Villeneuve JP; Huet PM
    Hepatology; 1986; 6(1):92-7. PubMed ID: 3484714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of somatostatin on hepatic and systemic hemodynamics in patients with cirrhosis of the liver: comparison with vasopressin.
    Bosch J; Kravetz D; Rodes J
    Gastroenterology; 1981 Mar; 80(3):518-25. PubMed ID: 6108897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of isosorbide-5-mononitrate on variceal pressure and systemic and splanchnic haemodynamics in patients with cirrhosis.
    Escorsell A; Feu F; Bordas JM; García-Pagán JC; Luca A; Bosch J; Rodés J
    J Hepatol; 1996 Apr; 24(4):423-9. PubMed ID: 8738728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitroglycerin improves the hemodynamic response to vasopressin in portal hypertension.
    Groszmann RJ; Kravetz D; Bosch J; Glickman M; Bruix J; Bredfeldt J; Conn HO; Rodes J; Storer EH
    Hepatology; 1982; 2(6):757-62. PubMed ID: 6815044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasopressin and vasopressin plus nitroglycerin for portal hypertension. Effects on systemic and splanchnic hemodynamics and coronary blood flow.
    Rector WG; Hossack KF
    J Hepatol; 1989 May; 8(3):308-15. PubMed ID: 2499616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug therapy of portal hypertension due to cirrhosis.
    Benhamou JP; Lebrec D
    Semin Liver Dis; 1982 Aug; 2(3):227-32. PubMed ID: 6129706
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of vasopressin and nicardipine on hemodynamics and liver function in patients with cirrhosis: comparison with vasopressin alone.
    Iwao T; Toyonaga A; Ikegami M; Oho K; Sumino M; Sakaki M; Shigemori H; Nakayama M; Sasaki E; Tanikawa K
    J Hepatol; 1993 Nov; 19(3):345-52. PubMed ID: 8151095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of vasopressin on haemodynamics in portal hypertensive rats receiving clonidine.
    Moreau R; Cailmail S; Lebrec D
    Liver; 1994 Feb; 14(1):45-9. PubMed ID: 8177029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of vasopressin on hepatic haemodynamics in the cirrhotic and non-cirrhotic rat.
    Jenkins SA; Day DW; Mooney B; Devitt P; Baxter JN; Taylor I; Shields R
    Langenbecks Arch Chir; 1985; 365(2):135-46. PubMed ID: 4046683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.